Consistent with this study, we also found the well-characterized biological MIF inhibitor ISO-1 to be less efficient in inhibiting AML cell survival and proliferation and to have no measurable effect on MΦ reprogramming, compared to 4-IPP. This evidence concerns the gene MIF and acute myeloid leukemia.